When expression of IRF8 was restored, AC levels dropped with a concomitant accumulation of C16:0-ceramide and sensitization of CML cells to Fas ligand-induced apoptosis in vitro and CML development in vivo [248]. This evidence concerns the gene IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive.